GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Pretax Margin %

Radiopharm Theranostics (ASX:RAD) Pretax Margin % : % (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Radiopharm Theranostics's Pre-Tax Income for the six months ended in Dec. 2023 was A$-24.73 Mil. Radiopharm Theranostics's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, Radiopharm Theranostics's pretax margin for the quarter that ended in Dec. 2023 was %.

The historical rank and industry rank for Radiopharm Theranostics's Pretax Margin % or its related term are showing as below:

ASX:RAD' s Pretax Margin % Range Over the Past 10 Years
Min: -336611.11   Med: -174225.59   Max: -11840.07
Current: -11840.07


ASX:RAD's Pretax Margin % is ranked worse than
92.14% of 1018 companies
in the Biotechnology industry
Industry Median: -154.275 vs ASX:RAD: -11840.07

Radiopharm Theranostics Pretax Margin % Historical Data

The historical data trend for Radiopharm Theranostics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Pretax Margin % Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23
Pretax Margin %
-336,611.11 -11,840.07

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % - - -4,284.59 - -

Competitive Comparison of Radiopharm Theranostics's Pretax Margin %

For the Biotechnology subindustry, Radiopharm Theranostics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Radiopharm Theranostics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Pretax Margin % falls into.



Radiopharm Theranostics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Radiopharm Theranostics's Pretax Margin for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-34.573/0.292
=-11,840.07 %

Radiopharm Theranostics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-24.727/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radiopharm Theranostics  (ASX:RAD) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Radiopharm Theranostics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Radiopharm Theranostics (ASX:RAD) Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines